Recombinant Monoclonal Anti-C-MET Antibody, Rabbit (1A1), Ready-To-Use

사용자 리뷰
제품 번호/규격
가격
수량
CAA-B003-7.5ml
$1100.00
ETA of in-stock products:2 business days
총 항목 수 제품 금액$ 0

제품 세부정보

  • Product Overview

    MET is a tyrosine kinase receptor for the hepatocyte growth factor. It is linked to functions such as cell proliferation, scattering, morphogenesis, and survival. Ligand binding at the cell surface induces autophosphorylation of MET that provides docking sites for downstream signaling molecules. The C-MET IHC Antibody (1A1) is a ready-to-use antibody working solution to detect C-MET across tumors to identify patients eligible for multiple targeted therapies. Kit product are manufactured in a dedicated GMP facility and are compliant with our ISO 13485 quality management system.

  • Product Specifications

    Analyte
    C-MET
    Format
    7.5ml
    Reactivity
    Human
    Species
    Rabbit
    Regulatory Status
    RUO
    Applicable Platform
    LEICA BOND III
  • Materials Provided

    Recombinant Monoclonal Anti-C-MET Antibody, Rabbit (1A1)

  • Application

    The kit is developed for use in the C-MET protein in the formalin-fixed, paraffin-embedded tissue. It is indicated as an aid in the assessment of C-MET expression in human tissues.

  • State

    Liquid

  • Storage

    Stored at 2°C to 8°C. The shelf life is 30 days from the date of opening.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

고객님도 확인한 상품

데이터 표시

Cancer Sample
  • Extensibility

    ACRO C-MET 1A1 expandable test: lung cancer, colorectal cancer, head and neck squamous cell cancer, liver cancer, gastric cancer.

     C-MET EXTENSIBILITY
     C-MET EXTENSIBILITY
     C-MET EXTENSIBILITY

    Use C-MET 1A1 kit to stain lung cancer, colorectal cancer, head and neck squamous cell cancer, liver cancer, gastric cancer tissue samples respectively.

  • Control Sample

     C-MET CONTROL SAMPLE

    Use ACRO C-MET 1A1 kit to stain human colorectal cancer tissue, positive cell membrane specific positive staining (staining intensity ≥ 1), no non-specific staining (staining intensity < 1) , no background staining (staining intensity < 1 ).

사용자 리뷰
댓글 남기기

프론티어 진행

 
의약품 개발 진행
  • 영어 이름:

    Hepatocyte growth factor receptor

  • 카테고리:

  • 상장 의약품 수:

    13 상세

  • 임상 의약품 수:

    74 상세

  • 최고 개발 단계:

    Approved

연락하기
신약 후보물질 라이선싱
더 많이 알아보기
  • 기본 제품 정보
  • 제품 세부정보
  • 고객님도 확인한 상품
  • 데이터 표시
  • 사용자 리뷰
문의하기

전화
글로벌: +1 800-810-0816 (무료)
아시아태평양: +86 400-682-2521

주소 서울특별시 송파구 법원로11길 11, 제3층 제비-314,315호